Product Information
EDARBYCLOR 40-25 MG TABLET is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $8.4960 per EA under NDC 60631042530. Its NADAC has been published 592 times since Feb 25, 2015.
Strength
40; 25 mg/1; mg/1
Manufacturer
Azurity Pharmaceuticals Inc.NDC
60631042530
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONEApproval Type
New Drug (NDA)
FDA Application
NDA202331On Market Since
2/1/2013
Pharmacological Classes
Price Statistics
The NADAC for EDARBYCLOR 40-25 MG TABLET has been published 592 times since Feb 25, 2015, and over the history we have for it it has risen 88.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.4960 per EA |
|---|---|
| All-time high | $8.5037 (May 14, 2025) |
| All-time low | $4.5107 (Feb 25, 2015) |
| 52-week high | $8.4978 |
| 52-week low | $8.4440 |
| Median price | $6.4445 |
| Average price | $6.5588 |
| Largest weekly change | +10.0% (Dec 27, 2023) |
| Weeks tracked | 592 |
| Tracking since | Feb 25, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Azilsartan kamedoxomil and chlorthalidone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of EDARBYCLOR 40-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EDARBYCLOR 40-25 MG TABLET, manufactured by Azurity Pharmaceuticals Inc., is $8.4960 per EA (NDC 60631042530), effective Jun 24, 2026.
How has the price of EDARBYCLOR 40-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for EDARBYCLOR 40-25 MG TABLET has risen 88.4%. It has been tracked across 592 weekly CMS publications since Feb 25, 2015.
What are the highest and lowest recorded NADAC prices for EDARBYCLOR 40-25 MG TABLET?
Since Feb 25, 2015, the NADAC for EDARBYCLOR 40-25 MG TABLET has ranged from a low of $4.5107 (Feb 25, 2015) to a high of $8.5037 (May 14, 2025), with a median of $6.4445 per EA.
Are there cheaper alternatives to EDARBYCLOR 40-25 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of EDARBYCLOR 40-25 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures EDARBYCLOR 40-25 MG TABLET?
EDARBYCLOR 40-25 MG TABLET (NDC 60631042530) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification